Digital Genome Market 2021 Growth, Scope, COVID-19 Impact Analysis, Top Key Players And Forecast, 2027 | Agilent Technologies Inc., bioMerieux, Becton Dickinson and Company, Genomic Health Inc

Allied Market Research published a new report, titled, "Digital Genome Market Global Opportunity Analysis and Industry Forecast, 2020-2027".

The report has offered an all-inclusive analysis of the global Digital Genome Market taking into consideration all the crucial aspects like growth factors, constraints, market developments, top investment pockets, future prospects, and trends. At the start, the report lays emphasis on the key trends and opportunities that may emerge in the near future and positively impact the overall industry growth.

Click Here To Access Free Sample Report:

https://www.alliedmarketresearch.com/request-sample/8564

Genomics is a traditional concept with traces of genome market traced back right from 1926 when a geneticist at the Jackson Laboratory Tom Roderick, coined the term genomics. In 1981, the 1st complete genome sequence of the human mitochondrion (16.6 kb), was registered. Then in 2003 the accomplishment of the Human Genome Project, sequencing of 3.2 billion base pairs of a DNA that make up the human genome, which took many years and cost hefty amounts of time and capital was completely sequenced, with every single human gene sequences were accessible in the public domain.

COVID – 19 scenario analysis:

The COVID-19 pandemic has emerged as a humanitarian as well as economic crisis, creating strain on the society and affecting millions of people and businesses

Industry closures and people are asked to stay in their homes which has cause taken a huge toll in terms of money and economic growth

Over 4 million people affected globally, with 300 thousand losing their lives due to SARS-CoV-2

Healthcare organizations are already working in battle mode, preparing new plans to respond growing COVID-19 patients, right from sourcing rapid diagnosing kits to sufficient PPE kits for workers

Get detailed COVID-19 impact analysis on the Digital Genome Market

https://www.alliedmarketresearch.com/request-for-customization/8564?reqfor=covid

Companies covered:

Agilent Technologies Inc., bioMerieux, Becton Dickinson and Company, Genomic Health Inc., GenMark Diagnostics Inc., Illumina, Pacific Bioscience, PerkinElmer Inc., Quest Diagnostics Inc., Qiagen and Thermo Fisher Scientific.

Technological advancements to boost the market growth:

Recent technological advancements and growing awareness regarding advantages in use of genomes for detection and treatment of diseases, primarily cancer is expected to drive growth of the digital genome market. For instance, the National Human Genome Research Institute (NHGRI) launched a strategic planning in February 2018, which will establish a plan of action for genomics research focusing on acceleration of breakthroughs and innovations in biomedical field.

Top impacting factors: Market Scenario Analysis:

Majority of intractable health challenges, especially cancer can be considered genomic as a disease. With digitization of the genome, healthcare professionals would be able to make a better decision regarding cancer treatment by understanding tumor’s genetic make-up. Digital genome would also aid in precision and customized medicine and development of highly targeted therapies with the potential to be applied across many diseases. These factors would fuel the market growth.

However, the untapped markets in the Asia Pacific region are evaluated to develop at a significant rate due to rise in geriatric populace, developing infrastructure and insurance administrations would create profitable ventures for digital genome market.

Rising demand for personalized medications to fuel the growth:

As per statistics and research by WHO, cancer is one of the prime causes of morbidity and mortality worldwide, accounting for almost 14 million cases in 2012. WHO also stats that 30-50% of deaths caused due to cancer can be reduced by appropriate treatment in early stages after diagnosis. Personalized medicine offers prominent techniques to fight diseases.

For Purchase Enquiry at:

https://www.alliedmarketresearch.com/purchase-enquiry/8564

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): 1-800-792-5285, 1-503-894-6022, 1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com
Follow Us on LinkedIn: https://www.linkedin.com/company/allied-market-research

About Allied Market Research:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting services to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.

This release was published on openPR.